Molecular Diagnostics
News on lab-developed tests and emerging diagnostic technologies.
Diasorin Nabs FDA 510(k) Clearance for Expanded Respiratory Panel
The firm said that its NxTag Respiratory Pathogen Panel v2 adds detection of the SARS-CoV-2 virus for a total of 21 viral and bacterial targets.
Earnings Roundup: DermTech, Exagen, Lucid Diagnostics, Oncocyte
These genomics and molecular diagnostics firms posted their quarterly financial results this week.
Oxford BioDynamics, King's College London to Develop Biomarkers for Rheumatoid Arthritis Prevention
Oxford BioDynamics will use its EpiSwitch 3D genomics platform to develop blood-based biomarkers of disease progression and response to the drug Orencia.
Centogene 2023 Revenues up 2 Percent, Firm Secures $20M in Funding
The German disease company said the growth is primarily driven by diagnostics revenues, especially in whole-exome and whole-genome sequencing tests.
OpGen to Execute 1-for-10 Reverse Stock Split
The reverse stock split is intended to bring the firm back into compliance with the Nasdaq's minimum bid price listing requirement of $1.00 per share.